Zevra Therapeutics Announces Details for Q3 2026 Financial Results Call
BOSTON, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases, today announced it will report corporate and financial results for the third quarter on Tuesday, November 3, 2026, via a news release after the market close, and will host a conference call/audio webcast at 4:30 p.m. ET that day.
Covered in this story
Call it yourself
No calls on $ZVRA yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Zevra Therapeutics Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.